XML 46 R34.htm IDEA: XBRL DOCUMENT v3.25.1
ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Jun. 30, 2025
Dec. 31, 2024
Oct. 04, 2024
Aug. 31, 2024
Jul. 25, 2024
Product Information [Line Items]              
Other receivables $ 4,043,769     $ 4,138,770      
Deferred offering costs     534,800      
Intangible assets 76,400,000     76,400,000      
Goodwill $ 21,372,960     $ 21,372,960      
Warrants to purchase common stock 238,594            
Provision for income taxes          
Warrant [Member]              
Product Information [Line Items]              
Warrants to purchase common stock           76,923  
Warrant [Member] | Series B Preferred Stock [Member]              
Product Information [Line Items]              
Options to purchase common stock 15,759            
Common Stock [Member] | Options Held [Member]              
Product Information [Line Items]              
Options to purchase common stock 23,930            
Minimum [Member]              
Product Information [Line Items]              
Assets will be amortized over their expected remaining life 15 years            
Maximum [Member]              
Product Information [Line Items]              
Assets will be amortized over their expected remaining life 20 years            
Scienture Inc [Member]              
Product Information [Line Items]              
Intangible assets $ 76,400,000           $ 76,400,000
Goodwill             $ 21,372,960
Federal Deposit Insurance Corp Limits [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]              
Product Information [Line Items]              
Concentration of credit risks and major customers percentage 10.00% 10.00%          
Tollo [Member] | Subsequent Event [Member]              
Product Information [Line Items]              
Note principal amount     $ 5,000,000        
Softell Inc [Member]              
Product Information [Line Items]              
Equity method investment ownership percentage 100.00%            
Integra Pharma Solutions LLC [Member]              
Product Information [Line Items]              
Equity method investment ownership percentage 100.00%       100.00%    
Bonum Health LLC [Member]              
Product Information [Line Items]              
Equity method investment ownership percentage 100.00%            
Bonum Health Inc [Member]              
Product Information [Line Items]              
Equity method investment ownership percentage 100.00%            
Scienture LLC [Member]              
Product Information [Line Items]              
Equity method investment ownership percentage 100.00%